Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Peerless Lion, officially known as Beijing Zhuocheng Huisheng Biotechnology, is a prominent biotechnology company specializing in the field of molecular diagnostics and in vitro diagnostics (IVD). Founded in 2010 and headquartered in Beijing, the company focuses on the research, development, and large-scale production of high-sensitivity PCR-based testing kits. Its extensive product portfolio addresses a wide range of clinical needs, including the detection of respiratory infections, enteric pathogens, vector-borne diseases, and sexually transmitted infections. Peerless Lion gained significant international recognition for its rapid development and global distribution of COVID-19 diagnostic reagents and automated extraction systems. The company serves a diverse clientele comprising hospitals, disease control centers, and research institutions, leveraging its proprietary multiplex PCR platform to provide rapid and accurate diagnostic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peerless Lion.